{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:45:50Z","timestamp":1774579550657,"version":"3.50.1"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by research grants of the Medical University of Lublin (DS174)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00005-018-0523-9","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T04:06:27Z","timestamp":1536379587000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia"],"prefix":"10.2478","volume":"67","author":[{"given":"Agata","family":"Szyma\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Bojarska-Junak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadiusz","family":"Drobiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Tomczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Roli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Hus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Hus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"523_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0952-7915(02)00013-4","volume":"15","author":"S Akira","year":"2003","unstructured":"Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15:5\u201311","journal-title":"Curr Opin Immunol"},{"key":"523_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2796.2007.01821.x","volume":"261","author":"B Albiger","year":"2007","unstructured":"Albiger B, Dahlberg S, Henriques-Normark B et al (2007) Role of the innate immune system in the host defence against bacterial infections: focus on the Toll-like receptors. J Int Med 261:511\u2013528","journal-title":"J Int Med"},{"key":"523_CR3","first-page":"239","volume":"42","author":"H Antosz","year":"2011","unstructured":"Antosz H, Sajewicz J, Marzec Kotarska B et al (2011) TLR2 expression in chronic lymphocytic leukemia B cells. Acta Haematol Pol 42:239\u2013249","journal-title":"Acta Haematol Pol"},{"key":"523_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bcmd.2012.03.006","volume":"49","author":"H Antosz","year":"2012","unstructured":"Antosz H, Sajewicz J, Marzec-Kotarska B et al (2012) TLR2 may influence the behavior of the malignant clone in B-CLL. Blood Cells Mol Dis 49:32\u201340","journal-title":"Blood Cells Mol Dis"},{"key":"523_CR5","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","volume":"96","author":"E Arvaniti","year":"2011","unstructured":"Arvaniti E, Ntoufa S, Papakonstantinou N et al (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica 96:1644\u20131652","journal-title":"Haematologica"},{"key":"523_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1096158","volume":"304","author":"JM Blander","year":"2004","unstructured":"Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014\u20131018","journal-title":"Science"},{"key":"523_CR7","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2008-02-140673","volume":"112","author":"D Chiron","year":"2008","unstructured":"Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C et al (2008) Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood 112:2205\u20132213","journal-title":"Blood"},{"key":"523_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.imbio.2016.06.009","volume":"222","author":"M Dajon","year":"2017","unstructured":"Dajon M, Iribarren K, Cremer I (2017) Toll-like receptor stimulation in cancer: a pro- and anti-tumor double-edged sword. Immunobiology 222:89\u2013100","journal-title":"Immunobiology"},{"key":"523_CR9","first-page":"239","volume":"1","author":"X Damo","year":"2004","unstructured":"Damo X, Haiying L, Mousa KK (2004) Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol 1:239\u2013246","journal-title":"Cell Mol Immunol"},{"key":"523_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910\u20131916","journal-title":"N Engl J Med"},{"key":"523_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3324\/haematol.2012.069369","volume":"98","author":"R Fo\u00e0","year":"2013","unstructured":"Fo\u00e0 R, Del Giudice I, Guarini A et al (2013) Clinical implications of the molecular genetics of chronic lymphocytic leukemia. Haematologica 98:675\u2013685","journal-title":"Haematologica"},{"key":"523_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-012-1460-z","volume":"91","author":"R Garcia-Mu\u00f1oz","year":"2012","unstructured":"Garcia-Mu\u00f1oz R, Galiacho VR, Llorente L (2012) Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol 91:981\u2013996","journal-title":"Ann Hematol"},{"key":"523_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2796.2008.02030.x","volume":"264","author":"P Ghia","year":"2008","unstructured":"Ghia P, Chiorazzi N, Stamatopoulos K (2008) Microenvironmental influences in chronic lymphocytic leukemia: the role of antigen stimulation. J Intern Med 264:549\u2013562","journal-title":"J Intern Med"},{"key":"523_CR14","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3324\/haematol.10975","volume":"92","author":"C Grandjenette","year":"2007","unstructured":"Grandjenette C, Kennel A, Gilbert C et al (2007) Expression of functional Toll-like receptors by B-chronic lymphocytic leukemia cells. Haematologica 92:1279\u20131281","journal-title":"Haematologica"},{"key":"523_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2567.2007.02651.x","volume":"122","author":"L Guangwei","year":"2007","unstructured":"Guangwei L, Yong Z (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122:149\u2013156","journal-title":"Immunology"},{"key":"523_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/annonc\/mdj120","volume":"17","author":"I Hus","year":"2006","unstructured":"Hus I, Podhorecka M, Bojarska-Junak A et al (2006) The clinical significance of ZAP-70 and CD38 expression in B-cell chronic leukemia. Ann Oncol 17:683\u2013690","journal-title":"Ann Oncol"},{"key":"523_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-014-0057-5","volume":"7","author":"JM Isaza-Correa","year":"2014","unstructured":"Isaza-Correa JM, Liang Z, Van den Berg A et al (2014) Toll-like receptors in the pathogenesis of human B cell malignancies. J Hematol Oncol 7:57","journal-title":"J Hematol Oncol"},{"key":"523_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S (2011) Toll-like receptors and their cosstalk with Rother innate receptors in infection and immunity. Immunity 34:637\u2013650","journal-title":"Immunity"},{"key":"523_CR19","doi-asserted-by":"publisher","first-page":"e2012052","DOI":"10.4084\/mjhid.2012.052","volume":"4","author":"E Kostareli","year":"2012","unstructured":"Kostareli E, Gounari M, Agathangelidis A et al (2012) Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antygen selection and microenvironmental interactions. Mediterr J Hematol Infect Dis 4:e2012052","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"523_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.28382","volume":"134","author":"K Li","year":"2014","unstructured":"Li K, Lv XX, Hua F (2014) Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide. Int J Cancer 134:692\u2013702","journal-title":"Int J Cancer"},{"key":"523_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.autrev.2007.11.027","volume":"7","author":"A Meyer-Bahlburg","year":"2008","unstructured":"Meyer-Bahlburg A, Rawlings DJ (2008) B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 7:313\u2013316","journal-title":"Autoimmun Rev"},{"key":"523_CR22","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A et al (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111:1524\u20131533","journal-title":"Blood"},{"key":"523_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","volume":"144","author":"M Muzio","year":"2008","unstructured":"Muzio M, Scielzo C, Bertilaccio MT et al (2008) Expression and function of Toll like receptors in chronic lymphocytic leukemia cells. Br J Haematol 144:507\u2013516","journal-title":"Br J Haematol"},{"key":"523_CR24","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1080\/10428190903115410","volume":"50","author":"M Muzio","year":"2009","unstructured":"Muzio M, Bertilaccio MT, Simonetti G et al (2009) The role of Toll-like receptors in chronic B-cell malignancies. Leuk Lymphoma 50:1573\u20131580","journal-title":"Leuk Lymphoma"},{"key":"523_CR25","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.4049\/jimmunol.172.6.3712","volume":"172","author":"MG Netea","year":"2004","unstructured":"Netea MG, Sutmuller R, Hermann C et al (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172:3712\u20133718","journal-title":"J Immunol"},{"key":"523_CR26","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","volume":"196","author":"S Ntoufa","year":"2016","unstructured":"Ntoufa S, Papakonstantinou N, Apollonio B et al (2016) B cell anergy modulated by TLR1\/2 and the miR-17\u223c92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4. J Immunol 196:4410\u20134417","journal-title":"J Immunol"},{"key":"523_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"LA O\u2019Neill","year":"2007","unstructured":"O\u2019Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7:353\u2013364","journal-title":"Nat Rev Immunol"},{"key":"523_CR28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Savitsky A, Cronkite EP et al (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219\u2013234","journal-title":"Blood"},{"key":"523_CR29","first-page":"395","volume":"34","author":"T Robak","year":"2003","unstructured":"Robak T (2003) Prognostic factors in chronic lymphocytic leukemia. Acta Haematol Pol 34:395\u2013405","journal-title":"Acta Haematol Pol"},{"issue":"Suppl 1","key":"523_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00005-016-0433-7","volume":"64","author":"J Rybka","year":"2016","unstructured":"Rybka J, Butrym A, Wr\u00f3bel T et al (2016) The expression of Toll-like receptors in patient with B-cell chronic lymphocytic leukemia. Arch Immunol Ther Exp 64(Suppl 1):147\u2013150","journal-title":"Arch Immunol Ther Exp"},{"key":"523_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1182\/blood-2015-05-646935","volume":"127","author":"M Wagner","year":"2016","unstructured":"Wagner M, Oelsner M, Moore A et al (2016) Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia. Blood 127:436\u2013448","journal-title":"Blood"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-018-0523-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:10Z","timestamp":1704228550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-018-0523-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1007\/s00005-018-0523-9","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,8]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}